Bone Morphogenetic Protein 10—A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation

BACKGROUND: Patients with atrial fibrillation (AF) face an increased risk of death and major adverse cardiovascular events (MACE). We aimed to assess the predictive value of the novel atrial‐specific biomarker BMP10 (bone morphogenetic protein 10) for death and MACE in patients with AF in comparison...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennings, Elisa, Blum, Steffen, Aeschbacher, Stefanie, Coslovsky, Michael, Knecht, Sven, Eken, Ceylan, Lischer, Mirko, Paladini, Rebecca E., Krisai, Philipp, Reichlin, Tobias, Rodondi, Nicolas, Beer, Jürg H., Ammann, Peter, Conte, Giulio, De Perna, Maria Luisa, Kobza, Richard, Blum, Manuel R., Bossard, Matthias, Kastner, Peter, Ziegler, André, Müller, Christian, Bonati, Leo H., Pfister, Otmar, Zuern, Christine S., Conen, David, Kühne, Michael, Osswald, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111531/
https://www.ncbi.nlm.nih.gov/pubmed/36926939
http://dx.doi.org/10.1161/JAHA.122.028255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111531/
https://www.ncbi.nlm.nih.gov/pubmed/36926939
http://dx.doi.org/10.1161/JAHA.122.028255

Ejemplares similares